PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
08-Feb-2023 Study Shows Novel Flavoprotein Fluorescence Measure is Correlated with Age-Related Macular Degeneration (AMD) Stage Businesswire
08-Feb-2023 HCB Joins NPG Health to Create Next Generation Healthcare Offering Businesswire
08-Feb-2023 Celanese Expanding Portfolio of Sustainable Products Across Acetyl Chain Businesswire
08-Feb-2023 Dr. Reddy’s included in Bloomberg Gender-Equality Index for the 6th year in a row and S&P Global’s Sustainability Yearbook for the 3rd year Businesswire
08-Feb-2023 EnPlusOne Biosciences Expands Scientific Advisory Board Businesswire
08-Feb-2023 Doreen Devine Joins Alliant Insurance Services’ New York Team Businesswire
08-Feb-2023 Lineage Provides Update on Auditory Neuronal Cell Transplant Program for the Treatment of Hearing Loss Businesswire
08-Feb-2023 AmerisourceBergen Releases 2022 ESG Summary Report to Share Progress and Impact on Environmental, Social and Governance Priorities Businesswire
08-Feb-2023 Strateos Appoints Alexander K. Arrow as Chief Financial Officer and Expands Team Businesswire
08-Feb-2023 Astria Therapeutics Initiates ALPHA-STAR Phase 1b/2 Clinical Trial of STAR-0215 in People with HAE Businesswire
08-Feb-2023 Canada's Biotech Sector Gets Boost with New Compensation Guide Businesswire
08-Feb-2023 Thermo Fisher Scientific Launches TrueMark STI Select Panel Businesswire
08-Feb-2023 AdaCore Joins Rust Foundation as Silver Member Businesswire
08-Feb-2023 Bionik Laboratories Reports Third Quarter Fiscal Year 2023 Financial Results Businesswire
08-Feb-2023 Andersen’s Aggressive Growth Moves Stateside: Expands Presence in Orange County, Adds New Offices in Des Moines and Pittsburgh Businesswire
08-Feb-2023 Appili Therapeutics Announces that FDA accepts the ATI-1501 NDA Businesswire
08-Feb-2023 Teva Reports Fourth Quarter and Full Year 2022 Financial Results Businesswire
08-Feb-2023 Bicycle Therapeutics to Participate in the SVB Securities Global Biopharma Conference Businesswire
08-Feb-2023 Silence Therapeutics to Present at SVB Securities Global Biopharma Conference Businesswire
08-Feb-2023 Pierre Fabre to Commercialize and Distribute the First Approved Allogeneic T-cell Immunotherapy in Europe Following Transfer of the European Commission Marketing Authorization of EBVALLO™ (tabelecleucel) Businesswire